These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3289388)
1. Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease. Schmidt EW; Rasche B; Ulmer WT; Konietzko N; Becker M; Fallise JP; Lorenz J; Ferlinz R Am J Med; 1988 Jun; 84(6A):63-9. PubMed ID: 3289388 [TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report. Moser KM; Smith RM; Spragg RG; Tisi GM Am J Med; 1988 Jun; 84(6A):70-4. PubMed ID: 3260074 [TBL] [Abstract][Full Text] [Related]
3. Natural history of alpha-1-protease inhibitor deficiency. Hutchison DC Am J Med; 1988 Jun; 84(6A):3-12. PubMed ID: 3289386 [TBL] [Abstract][Full Text] [Related]
4. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG; Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936 [TBL] [Abstract][Full Text] [Related]
5. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615 [TBL] [Abstract][Full Text] [Related]
6. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. Gadek JE; Klein HG; Holland PV; Crystal RG J Clin Invest; 1981 Nov; 68(5):1158-65. PubMed ID: 7028785 [TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors in chronic obstructive pulmonary disease. Barnett TB; Gottovi D; Johnson AM Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep. Smith RM; Traber LD; Traber DL; Spragg RG J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051 [TBL] [Abstract][Full Text] [Related]
10. Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer. Marchandise FX; Mathieu B; Francis C; Sibille Y Eur Respir J; 1989 Jul; 2(7):623-9. PubMed ID: 2476329 [TBL] [Abstract][Full Text] [Related]
11. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction. Abboud RT; Rushton JM; Grzybowski S Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728 [TBL] [Abstract][Full Text] [Related]
12. Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous). Sandhaus RA; Stocks J; Rouhani FN; Brantly M; Strauss P COPD; 2014 Feb; 11(1):17-25. PubMed ID: 23822603 [TBL] [Abstract][Full Text] [Related]
13. Comparative biochemical efficacy analysis of an alpha Li Z; Franke RM; Morris D; Yel L Pulm Pharmacol Ther; 2022 Jun; 73-74():102124. PubMed ID: 35314325 [TBL] [Abstract][Full Text] [Related]
14. Alpha-1-proteinase inhibitor in inflammatory states of humans and laboratory animals. Cochrane CG Am J Med; 1988 Jun; 84(6A):75-9. PubMed ID: 3260075 [TBL] [Abstract][Full Text] [Related]
15. Abnormal interaction of alpha 1-antitrypsin and leukocyte elastolytic activity in patients with chronic obstructive pulmonary disease. Martin WJ; Taylor JC Am Rev Respir Dis; 1979 Aug; 120(2):411-9. PubMed ID: 314251 [TBL] [Abstract][Full Text] [Related]
16. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis. Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482 [TBL] [Abstract][Full Text] [Related]
18. Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor. Smith RM; Spragg RG Am J Med; 1988 Jun; 84(6A):48-51. PubMed ID: 3260073 [TBL] [Abstract][Full Text] [Related]